Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 132458, 11 pages
http://dx.doi.org/10.1155/2015/132458
Research Article

Enhanced Levels of Chemokines and Their Receptors in the Colon of Microscopic Colitis Patients Indicate Mixed Immune Cell Recruitment

1Örebro University, Department of Biomedicine, School of Health and Medical Sciences, 70182 Örebro, Sweden
2University of Glasgow, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, Glasgow G128TA, UK
3Örebro University, Division of Gastroenterology, Department of Medicine, Örebro University Hospital, School of Health and Medical Sciences, 70185 Örebro, Sweden
4Örebro University Hospital, Department of Microbiology and Immunology, 70185 Örebro, Sweden

Received 13 June 2014; Accepted 7 September 2014

Academic Editor: H. Barbaros Oral

Copyright © 2015 Sezin Günaltay et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Tysk, A. Wickbom, N. Nyhlin, S. Eriksson, and J. Bohr, “Recent advances in diagnosis and treatment of microscopic colitis,” Annals of Gastroenterology, vol. 24, no. 4, pp. 253–262, 2011. View at Google Scholar · View at Scopus
  2. D. S. Pardi and C. P. Kelly, “Microscopic colitis,” Gastroenterology, vol. 140, no. 4, pp. 1155–1165, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Münch, D. Aust, J. Bohr et al., “Microscopic colitis: Current status, present and future challenges: statements of the European Microscopic Colitis Group,” Journal of Crohn's and Colitis, vol. 6, no. 9, pp. 932–945, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Mahajan, J. R. Goldblum, S.-Y. Xiao, B. Shen, and X. Liu, “Lymphocytic colitis and collagenous colitis: a review of clinicopathologic features and immunologic abnormalities,” Advances in Anatomic Pathology, vol. 19, no. 1, pp. 28–38, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Nishida, K. Murase, H. Isomoto et al., “Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease,” Hepato-Gastroenterology, vol. 49, no. 45, pp. 678–682, 2002. View at Google Scholar · View at Scopus
  6. W. R. Brown and S. Tayal, “Microscopic colitis. A review,” Journal of Digestive Diseases, vol. 14, no. 6, pp. 277–281, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. A. M. Levy, K. Yamazaki, V. P. van Keulen et al., “Increased eosinophil infiltration and degranulation in colonic tissue from patients with collagenous colitis,” American Journal of Gastroenterology, vol. 96, no. 5, pp. 1522–1528, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Ayata, S. Ithamukkala, H. Sapp et al., “Prevalence and significance of inflammatory bowel disease-like morphologic features in collagenous and lymphocytic colitis,” The American Journal of Surgical Pathology, vol. 26, no. 11, pp. 1414–1423, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Göranzon, A. K. Kumawat, E. Hultgren-Hörnqvist et al., “Immunohistochemical characterization of lymphocytes in microscopic colitis,” Journal of Crohn's and Colitis, vol. 7, no. 10, pp. e434–e442, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Zlotnik and O. Yoshie, “Chemokines: a new classification system and their role in immunity,” Immunity, vol. 12, no. 2, pp. 121–127, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Rancez, A. Couëdel-Courteille, and R. Cheynier, “Chemokines at mucosal barriers and their impact on HIV infection,” Cytokine & Growth Factor Reviews, vol. 23, no. 4-5, pp. 233–243, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Rossi and A. Zlotnik, “The biology of chemokines and their receptors,” Annual Review of Immunology, vol. 18, pp. 217–243, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. A. K. Kumawat, H. Strid, K. Elgbratt, C. Tysk, J. Bohr, and E. Hultgren Hörnquist, “Microscopic colitis patients have increased proportions of Ki67+ proliferating and CD45RO+ active/memory CD8+ and CD4+8+ mucosal T cells,” Journal of Crohn's and Colitis, vol. 7, no. 9, pp. 694–705, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. J. R. Groom and A. D. Luster, “CXCR3 ligands: redundant, collaborative and antagonistic functions,” Immunology and Cell Biology, vol. 89, no. 2, pp. 207–215, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Bachelerie, A. Ben-Baruch, A. M. Burkhardt et al., “International union of pharmacology. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors,” Pharmacological Reviews, vol. 66, no. 1, pp. 1–79, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. S. J. Ono, T. Nakamura, D. Miyazaki, M. Ohbayashi, M. Dawson, and M. Toda, “Chemokines: roles in leukocyte development, trafficking, and effector function,” Journal of Allergy and Clinical Immunology, vol. 111, no. 6, pp. 1185–1199, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. S. P. Hogan, M. E. Rothenberg, E. Forbes, V. E. Smart, K. I. Matthaei, and P. S. Foster, “Chemokines in eosinophil-associated gastrointestinal disorders,” Current Allergy and Asthma Reports, vol. 4, no. 1, pp. 74–82, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. N. P. Zimmerman, R. A. Vongsa, M. K. Wendt, and M. B. Dwinell, “Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 14, no. 7, pp. 1000–1011, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. C. H. Kim, “Chemokine-chemokine receptor network in immune cell trafficking,” Current Drug Targets: Immune, Endocrine and Metabolic Disorders, vol. 4, no. 4, pp. 343–361, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. P. J. Koelink, S. A. Overbeek, S. Braber et al., “Targeting chemokine receptors in chronic inflammatory diseases: an extensive review,” Pharmacology and Therapeutics, vol. 133, no. 1, pp. 1–18, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. V. M. Dong, D. H. McDermott, and R. Abdi, “Chemokines and diseases,” European Journal of Dermatology, vol. 13, no. 3, pp. 224–230, 2003. View at Google Scholar · View at Scopus
  23. P. H. Carter, “Chemokine receptor antagonism as an approach to anti-inflammatory therapy: “just right” or plain wrong?” Current Opinion in Chemical Biology, vol. 6, no. 4, pp. 510–525, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Gijsbers, K. Geboes, and J. Van Damme, “Chemokines in gastrointestinal disorders,” Current Drug Targets, vol. 7, no. 1, pp. 47–64, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. U. P. Singh, C. Venkataraman, R. Singh, and J. W. Lillard Jr., “CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication,” Endocrine, Metabolic and Immune Disorders: Drug Targets, vol. 7, no. 2, pp. 111–123, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Mantovani, P. A. Gray, J. van Damme, and S. Sozzani, “Macrophage-derived chemokine (MDC),” Journal of Leukocyte Biology, vol. 68, no. 3, pp. 400–404, 2000. View at Google Scholar · View at Scopus
  27. U. Yamashita and E. Kuroda, “Regulation of macrophage-derived chemokine (MDC, CCL22) production,” Critical Reviews in Immunology, vol. 22, no. 2, pp. 105–114, 2002. View at Google Scholar · View at Scopus
  28. I. Shachar and N. Karin, “The dual roles of inflammatory cytokines and chemokines in the regulation of autoimmune diseases and their clinical implications,” Journal of Leukocyte Biology, vol. 93, no. 1, pp. 51–61, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. A. D. Luster, “The role of chemokines in linking innate and adaptive immunity,” Current Opinion in Immunology, vol. 14, no. 1, pp. 129–135, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. V. Appay and S. L. Rowland-Jones, “RANTES: a versatile and controversial chemokine,” Trends in Immunology, vol. 22, no. 2, pp. 83–87, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Romagnani, “Cytokines and chemoattractants in allergic inflammation,” Molecular Immunology, vol. 38, no. 12-13, pp. 881–885, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Suzuki, H. Yoneyama, and H. Asakura, “Role of interferon-γ-inducible protein (IP)-10/ (IP-10/CXCL10) in ulcerative colitis; a review of the present status,” in Ulcerative Colitis-Epidemiology, Pathogenesis and Complications, pp. 103–116, 2011. View at Google Scholar
  33. K. A. Papadakis, “Chemokines in inflammatory bowel disease,” Current Allergy and Asthma Reports, vol. 4, no. 1, pp. 83–89, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. C. T. Murphy, K. Nally, F. Shanahan, and S. Melgar, “Shining a light on intestinal traffic,” Clinical and Developmental Immunology, vol. 2012, Article ID 808157, 14 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Shibahara, J. N. Wilcox, T. Couse, and J. L. Madara, “Characterization of epithelial chemoattractants for human intestinal intraepithelial lymphocytes,” Gastroenterology, vol. 120, no. 1, pp. 60–70, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. J. R. Groom and A. D. Luster, “CXCR3 in T cell function,” Experimental Cell Research, vol. 317, no. 5, pp. 620–631, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. A. K. Kumawat, H. Strid, C. Tysk, J. Bohr, and E. H. Hörnquist, “Microscopic colitis patients demonstrate a mixed Th17/Tc17 and Th1/Tc1 mucosal cytokine profile,” Molecular Immunology, vol. 55, no. 3-4, pp. 355–364, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Jessurun, J. H. Yardley, F. M. Giardiello, S. R. Hamilton, and T. M. Bayless, “Chronic colitis with thickening of the subepithelial collagen layer (collagenous colitis): histopathologic findings in 15 patients,” Human Pathology, vol. 18, no. 8, pp. 839–848, 1987. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Wagner, M. Lampinen, P. Sangfelt, M. Agnarsdottir, and M. Carlson, “Budesonide treatment of patients with collagenous colitis restores normal eosinophil and T-cell activity in the colon,” Inflammatory Bowel Diseases, vol. 16, no. 7, pp. 1118–1126, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. B. S. McKenzie, R. A. Kastelein, and D. J. Cua, “Understanding the IL-23-IL-17 immune pathway,” Trends in Immunology, vol. 27, no. 1, pp. 17–23, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. N. Kamada, T. Hisamatsu, S. Okamoto et al., “Unique CD14+ intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-γ axis,” Journal of Clinical Investigation, vol. 118, no. 6, pp. 2269–2280, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. D. McGovern and F. Powrie, “The IL23 axis plays a key role in the pathogenesis of IBD,” Gut, vol. 56, no. 10, pp. 1333–1336, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. R. Mahida, “The key role of macrophages in the immunopathogenesis of inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 6, no. 1, pp. 21–33, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Viola and A. D. Luster, “Chemokines and their receptors: drug targets in immunity and inflammation,” Annual Review of Pharmacology and Toxicology, vol. 48, pp. 171–197, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. F. Fernández-Bañares, J. Casalots, A. Salas et al., “Paucicellular lymphocytic colitis: is it a minor form of lymphocytic colitis A clinical pathological and immunological study,” American Journal of Gastroenterology, vol. 104, no. 5, pp. 1189–1198, 2009. View at Publisher · View at Google Scholar · View at Scopus